Delivery Order SPE2DR25D1200-SPE2DR26FMG3E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (a combination respiratory medication) in the amount of $9,582.39 with an ultimate completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $27,169.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $19,941.01 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location...
- The Defense Logistics Agency awarded a delivery order valued at $11,278.97 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,167.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,317.57 to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price, non-set-aside delivery order is scheduled for completion by June 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine procurement...
- The Defense Logistics Agency awarded a delivery order valued at $28,804.38 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication indicated for chronic obstructive pulmonary disease management. The order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,768.87 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (60-unit package), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which closes on August 19, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,069.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 10, 2025. The contract represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FMG3EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,897.40 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle enables AmerisourceBergen to serve as a global pharmaceutical supplier supporting military healthcare programs and the Defense Health Agency. The company's federal contracting profile demonstrates extensive experience fulfilling pharmaceutical and medical supply requirements through the DLA Medical Supply Chain, positioning it as a critical vendor for military and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 11/4/25 |